We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeut... Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. Show more
Halozyme to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, Feb. 27, 2024 SAN DIEGO, Feb. 27, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.19 | -3.05128205128 | 39 | 39.28 | 37.73 | 751176 | 38.31354046 | CS |
4 | -2.49 | -6.17866004963 | 40.3 | 41.6 | 37.73 | 863669 | 39.7488304 | CS |
12 | 3.06 | 8.80575539568 | 34.75 | 42.64 | 33.15 | 1050065 | 38.59488243 | CS |
26 | 1.55 | 4.27468284611 | 36.26 | 42.82 | 32.83 | 1168137 | 37.53878997 | CS |
52 | 2.27 | 6.38716938661 | 35.54 | 45 | 29.85 | 1102619 | 37.41447053 | CS |
156 | -8.04 | -17.5354416576 | 45.85 | 59.46 | 29.85 | 1099837 | 41.23719506 | CS |
260 | 21.72 | 134.990677439 | 16.09 | 59.46 | 12.71 | 1193257 | 34.78562162 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions